The Pennant Group Third Quarter 2026 Earnings Call - PENNANT GROUP INC

Financial Performance:

• Reported Q3 2026 total revenue of $302.3 million, a 32% year-over-year increase.
• Adjusted EBITDA reached $24.7 million (up 42.4%), while adjusted EBITDA prior to Non-Controlling Interests (NCI) grew to $26.1 million (up 44%).
• Adjusted diluted earnings per share (EPS) were $0.35, representing a 16.7% increase; GAAP diluted EPS were $0.26.
• Cash flow from operations was $25.1 million for the quarter and $43.5 million year-to-date.
• Liquidity position included $103 million outstanding on the line of credit and $18.4 million in cash on hand.
• Net debt to adjusted EBITDA ratio stood at 1.95x.
• Elevated employee benefits costs impacted margins, representing an approximate 50 basis point drag on revenue; these costs are organization-wide, not limited to acquired units.

Guidance and Future Outlook:

• Management reaffirmed full-year 2026 guidance despite higher-than-expected benefits costs and integration challenges.
• Fourth-quarter projections incorporate expectations for elevated benefits expenses similar to Q3 levels due to year-end utilization.
• The company anticipates a recovery in senior living occupancy in Q4, with significant growth expected to materialize in 2027 as new communities stabilize.
• Long-term goals focus on the five key initiatives: leadership development, clinical excellence, margin expansion, growth, and employee experience.
• The home health final rule is viewed as a modest step (2.1% rate increase) but deemed insufficient to offset inflation; the company expects to navigate new program integrity measures successfully.

Business Segments and Product Lines:

• Home Health & Hospice: Segment revenue grew 38.2% to $239.8 million; adjusted EBITDA rose 42% to $38.1 million. Total home health admissions grew 39.4%, with same-store admissions up 8% and Medicare admissions up 12%. Same-store margin increased by 80 basis points despite rate declines.
• Senior Living: Segment revenue increased 12.6% to $62.4 million; adjusted EBITDA remained flat at $5.7 million due to integration lumps and occupancy challenges in specific markets.
• Acquisitions: Added 16 senior living communities since the prior year, including River Center in Arizona (August) and Main Place Senior Living in California (September, real estate purchase).
• Integrations: Completion of the transition for 54 locations acquired from UnitedHealth and Amedisys in the Southeast, with the final EMR transition completed October 31.
• Clinical Metrics: Potentially preventable hospitalization rates improved to 9.9% (vs. 10.8% industry average); CMS Hospice Quality Composite score reached 98.3% (vs. 96.2% industry average).

Market and Competitive Landscape:

• Serving nearly 40% more home health patients, 35% more hospice patients, and 10% more senior living residents compared to the prior year.
• The company is strategically positioned for managed care opportunities by leveraging high clinical outcomes (star ratings, low hospitalization rates) to negotiate better rates and access to provider networks.
• The home health industry faces underfunding and increased scrutiny on fraud; Pennant supports CMS's anti-fraud efforts but warns that new measures may burden legitimate providers.
• Competitive advantage is driven by a "flywheel" model where local leaders elevate peers to support transitions, enabling sustainable same-store growth even during periods of rapid acquisition.

Risks and Challenges:

• Employee Benefits Costs: Volatility in benefits expenses created margin pressure in Q3 and is expected to continue into Q4; the company is working to manage these predictably.
• Integration Lumps: Senior living segment margins were impacted by concentrated transition challenges in two specific markets where growth outpaced leadership capacity.
• Operational Disruption: The final waves of the UnitedHealth/Amedisys integration caused ordinary census disruption as clinicians managed EMR transitions.
• Regulatory Headwinds: The new home health final rule includes broad program integrity measures that may impose administrative burdens.
• Payor Pressure: Stricter scrutiny on Medicaid waivers and potential rate cuts in new acquisition geographies (e.g., Southeast) pose revenue risks.

Management Commentary and Tone:

• Management conveyed strong confidence in the long-term strategy and the fundamental strength of the operating model, emphasizing that short-term volatility is a byproduct of aggressive growth.
• Tone was optimistic regarding the quality of leadership development, noting the addition of over 100 CEOs-in-training this year.
• CEO Brent Garasoli highlighted the success of the local leadership model in driving clinical excellence and financial performance.
• CFO Lynette Walbaum and President John Gochner emphasized that the senior living challenges are isolated to specific markets and not systemic to the broader portfolio.

Analyst Questions and Answers:

• Raj Kumar (Stevens): Asked about Amethyst/UnitedHealth integration timing and senior living occupancy recovery. Management confirmed EMR transition is complete, disruption is in line with guidance, and expects recovery in Q4 as leadership stabilizes the two affected markets.
• Brian Tanquilot (Jefferies): Inquired about guidance maintenance and rate renegotiation in the Southeast. Management reaffirmed full-year guidance, noted that the drop in revenue per episode is due to wage index differences rather than rate cuts, and sees upside in managed care rate negotiations.
• Ben Hendricks (RBC): Asked about the leadership pipeline for senior living. Management clarified that 30+ senior living CEOs-in-training have graduated, but existing leaders faced bandwidth challenges due to the volume of acquisitions; a robust pipeline remains to fill future gaps.
• Jared Hassa (William Blair): Requested sizing of benefits costs and payer trends. Costs were ~50bps of revenue in Q3 and expected to be similar in Q4. Payers are increasingly focusing on network narrowing and rewarding high-quality providers with proven clinical outcomes.
• Steve Baxter (Wells Fargo): Clarified that benefits cost increases were organization-wide, not just acquired entities. Confirmed disruption in the final UnitedHealth transition was volume-driven and consistent with prior expectations.

Other Key Points:

• The company operates as a holding company with independent subsidiaries; the "Service Center" provides administrative support.
• The "Amethyst" and "UnitedHealth/Amedisys" integrations are described as the largest in company history, involving 54+ locations.
• Management highlighted specific high-performing units (Simbi in Utah, Harvest Home in Texas) as examples of successful turnaround and local leadership execution.
• The strategic real estate purchase of Main Place Senior Living in Orange, CA, allows the company to capture value from operational improvements while securing long-term stability.